Top 50 Medical VC Funds & Investors in Sweden (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Chalmers Ventures AB
VC Fund
|
13 | Sweden | Pre-Seed, Seed | Software, Biotechnology, Information Technology | $5k–$2.7M |
|
Almi Invest
VC Fund
|
13 | Sweden, United States, Ukraine | Seed, Pre-Seed | Software, Health Care, Information Technology | $193k–$2.2M |
|
Sciety
VC Fund
|
9 | Sweden, Ukraine | Seed, Series A | Health Care, Biotechnology, Medical | $128k–$6.3M |
|
Hadean Ventures
VC Fund
|
4 | Norway, Sweden, Germany | Series A, Series B | Biotechnology, Health Care, Medical | $4.3M–$79M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $1k–$17M |
|
Partnerinvest Norr
VC Fund
|
3 | Sweden, United States | Seed, Series A | Software, Manufacturing, Information Technology | $588k–$5.3M |
|
SEB Venture Capital
VC Fund
|
3 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.2M–$23M |
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
Sweet Studio
VC Fund
|
3 | Sweden | Pre-Seed | iOS, Apps, Audio | $145k–$400k |
|
Bonit Capital
VC Fund
|
3 | Sweden, United States, Germany | Seed, Series A | Health Care, Medical, Apps | $1.8M–$4.2M |
|
Industrifonden
VC Fund
|
3 | Sweden, United States, Denmark | Series A, Seed | Biotechnology, Software, Information Technology | $1.3M–$21M |
|
Norrsken VC
VC Fund
|
3 | Sweden, United Kingdom, Germany | Seed, Series A | Software, Artificial Intelligence, Health Care | $1.1M–$56M |
|
Jovitech Invest
VC Fund
|
2 | Sweden | Seed | Solar, Medical, Recycling | $395k–$1M |
|
Creandum
VC Fund
|
2 | Sweden, Germany, United States | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.8M–$80M |
|
Sting Capital
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Software, Apps, Medical | $216k–$724k |
|
Life Science Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Medical, Biotechnology, Biopharma | $310k–$4.6M |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Germany | Seed, Series A | Health Care, Medical, Fitness | $1.3M–$20M |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
LU Ventures
VC Fund
|
2 | Sweden | Venture - Series Unknown | Medical, Biotechnology | $336k–$1.6M |
|
Sweet Capital
VC Fund
|
2 | United States, United Kingdom, Sweden | Seed, Series A | Apps, Software, Mobile | $1.8M–$32M |
|
Fåhraeus Startup and Growth
VC Fund
|
2 | Sweden, Denmark, Finland | Seed, Venture - Series Unknown | Medical, Biotechnology, Genetics | $772k–$5.6M |
|
GU Ventures
VC Fund
|
2 | Sweden, United States | Seed, Series A, Venture - Series Unknown | Pharmaceutical, Medical, Health Care | $794k–$73M |
|
Otiva
VC Fund
|
2 | Sweden, France, United Kingdom | Seed, Series A, Series B | Fashion, Lifestyle, Marketplace | $1.6M–$12M |
|
Flerie Invest
VC Fund
|
2 | Sweden, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Pharmaceutical | $2.5M–$75M |
|
Uppsala universitet Invest AB
VC Fund
|
2 | Sweden | Seed | Medical, Health Diagnostics, Health Care | $1.7M–$1.8M |
|
Karolinska
VC Fund
|
2 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Project A Ventures
VC Fund
|
2 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, E-Commerce, Artificial Intelligence | $1.5M–$75M |
|
3T Invest
VC Fund
|
2 | Sweden | Seed, Series A | Medical, Health Care, Lifestyle | |
|
Index Ventures
VC Fund
|
2 | United States, United Kingdom, France | Series A, Series B, Seed | Software, E-Commerce, Internet | $1.4M–$100M |
|
Heartcore Capital
VC Fund
|
2 | Denmark, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, FinTech | $1.3M–$58M |
|
Metsa Spring
VC Fund
|
2 | Finland, Sweden | Seed, Series A | GreenTech, Sustainability, Chemical | $395k–$8.3M |
|
Scale Capital
VC Fund
|
2 | Denmark, Norway, Sweden | Seed, Venture - Series Unknown | Software, Information Technology, SaaS | $1M–$6.1M |
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9M–$135M |
|
Unruly Capital
VC Fund
|
1 | United Kingdom, United States, Germany | Seed, Pre-Seed | Biotechnology, CleanTech, Manufacturing | |
|
DHS Venture Partners
VC Fund
|
1 | Sweden | Pre-Seed, Seed | Software, Big Data, Mobile Apps | |
|
GOBIA Enterprises
VC Fund
|
1 | Sweden | Seed | Eyewear, Health Care, Health Diagnostics | |
|
Annexstruktur
VC Fund
|
1 | Sweden | Series A | Medical, Life Science, Biotechnology | |
|
3B Ventures
VC Fund
|
1 | Sweden | Series A | Medical, Biopharma | |
|
Navigare Ventures
VC Fund
|
1 | Sweden, Denmark | Seed, Pre-Seed | Biotechnology, Health Care, Energy | |
|
Neomed Management
VC Fund
|
1 | Switzerland, United States, Italy | Series B, Series C | Health Care, Biotechnology, Medical | |
|
Bonnier Capital
VC Fund
|
1 | Sweden, Finland, Germany | Seed, Series A | Internet, Software, E-Commerce | $1M–$21M |
|
Conor Venture Partners
VC Fund
|
1 | Finland, United States, Sweden | Series A, Series B, Seed | Software, Analytics, Semiconductor | $1.1M–$16M |
|
BackingMinds
VC Fund
|
1 | Sweden, Denmark, Finland | Seed, Pre-Seed | SaaS, Energy, Software | $772k–$8.2M |
|
Sunstone Life Science Ventures
VC Fund
|
1 | Denmark, Sweden, Switzerland | Series A, Series B | Biotechnology, Health Care, Medical | $5.5M–$52M |
|
Butterfly Ventures
VC Fund
|
1 | Finland, Sweden, Norway | Seed, Pre-Seed | Health Care, Software, Information Technology | $110k–$4.3M |
|
Incos Invest
VC Fund
|
1 | Italy, Sweden | Seed, Convertible Note | Travel, Boating, Medical | |
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $16M–$176M |
|
20 North Street
VC Fund
|
1 | Sweden | Medical, mHealth, Wireless | ||
|
Ferd
VC Fund
|
1 | Norway, Sweden, United States | Private Equity, Series A | Software, Energy, Information Technology | $2.2M–$14M |
|
Accel
VC Fund
|
1 | United States, India, United Kingdom | Series A, Series B, Seed | Software, SaaS, Information Technology | $1.6M–$74M |
| Access all 209 VC funds in Sweden Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 211
- Round size: Seed $290k–$2.7M; Pre-Seed $5k–$309k
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Anferra — Anferra specializes in hydrometallurgy, utilizing methods for resource-efficient recycling of steel industry waste into iron chloride.
- Arkeon Technologies — Arkeon Technologies is a deep-tech company developing innovative solutions for scalable superconducting quantum computing. Its patented technology enables precise post-fabrication tuning of qubit frequencies, improving quantum chip performance, yield, and reliability. By addressing key manufacturing challenges, Arkeon helps accelerate thedevelopment of large-scale quantum processors for next-generation computing.
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Sweden, United States, Ukraine
Investor stats
- Total investments: 278
- Round size: Seed $193k–$2.2M; Pre-Seed $236k–$1.4M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- FirstQFM — FirstQFM offers patent-pending AI foundation models for quantum computing.
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 46
- Round size: Seed $128k–$2.3M; Series A $439k–$6.3M
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- Encare — Encare was established in 2009 to implement the ERAS Protocols on a global basis by- providing training to health care professionals on the ERAS Protocols- providing an interactive and web-based information system for evidence based - best practice management (EBM)The company has developed an interactive, user-friendly interface forthe collection, documentation and follow-up on critical performance and quality parameters as lined out by leading clinical experts in respective protocol[1] based on, at any time, best practice and evidence.The data collected in the web-based solution is interactive and offers immediate feedback of performance, which will generate significant and sustainable improvement of efficiency and quality of care as well as generate substantial health care savings.Encare has the rights to commercialize surgical protocols developed by the ERAS Society. The company has so far rolled out the audit system to more than 120 hospitals in Canada, France, Norway, Poland, Sweden, South Africa, Switzerland, the United Kingdom, Argentina, Mexico, Colombia, Brazil, Singapore and the United States.The ERAS Society was formed in 2001 with the aim to establish evidence based protocols as best practice standards in perioperative care. ERAS Society has published a wide range of publications regarding protocols and guidelines for enhanced recovery after surgery.
- Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
- Single Technologies — Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become the instigator of 3-D Sequencing.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Norway, Sweden, Germany
Investor stats
- Total investments: 32
- Round size: Series A $4.3M–$79M; Series B $4.5M–$68M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $105M in 2021
Portfolio highlights
- Ribbon Bio —
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 49
- Round size: Seed $1.6M–$4.2M; Pre-Seed $1k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
- Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
- Augmented Hearing — Augmented Hearing is creating game-changing technology that will be used in fields such as voice assistants, hearing health, environmental noise suppression in phone calls, and many more.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Sweden, United States
Investor stats
- Total investments: 67
- Round size: Seed $588k–$2.1M; Series A $1.5M–$5.3M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- Senseworks — Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
- Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
- Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 70
- Round size: Series A $1.2M–$11M; Series B $2.2M–$23M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — The Operational Data Fabric from Apica unifies and connects all your data using a revolutionary Active Observability architecture.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 172
- Round size: Seed $549k–$5.9M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Finch — Optimize building design with AI and graph technology. Get immediate feedback on performance, detect errors and find optimal solutions.
- ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
- Valuebeat — Grow your culture. Backed by data. Platypus is the HR and recruitment tool that measures cultural drivers of people across the organization to help you qualify decisions on hiring and managing your culture.
We co-found companies, dedicating our in-house team of designers, developers, and marketers to bring ideas to life. With every venture we co-found, our mission is to advance the consumer experience across industries with world-class technology, data-informed design, and lots of heart. Are you an entrepreneur who shares our mission?
Show more...Investment focus
- Industry: iOS, Apps, Audio
- Stage:Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Pre-Seed $145k–$400k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Koo! — Koo! is an audio based social networking service that let users record and listen to 1-minute audio clips called Koos.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- Stride Leadership — Stride is the revolutionary leadership product built to help become a confident leader. For too long, we’ve been taught that leadership is an elite act that’s linked to your job title. Now you hold leadership development in your hand, regardless of your age, job title, or seniority.With Stride, you’ll learn what it truly means to lead, and how todo it. We’ll bust common myths and you’ll discover which style of leadership is the best fit for you. Designed by leadership and design experts, Stride will help you learn the mindset required, the basics of leadership, and techniques for dealing with inevitable challenges. Whether you’re new to leadership or you’re a seasoned professional you’ll love learning and forming new habits with Stride.
Bonit Capital is a Swedish family-owned investment company. We invest across sectors and asset classes, including social investments and outcome models.Venture Capital - We invest in ambitious founders within the life science sector. We take an active ownership approach by providing capital, industry expertise and access to an internationalnetwork. Our focus areas are digital health, medical technology and diagnostics.Private Equity - We invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, with the aim to produce superior returns and meaningful portfolio diversification.Listed Equity - Our strategy is to obtain a broad market exposure through mainly external mandates, and to seek superior returns in individual shares primarily in life science. Among Bonit's main holdings are the world-leading medtech company Elekta AB, founded by Laurent Leksell.Leksell Social Ventures - LSV is the first impact investor in Sweden with a focus on outcome models and direct investments in the areas of mental health, education and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development and networking with private, public and nonprofit actors.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed, Series A
- Geography: Sweden, United States, Germany
Investor stats
- Total investments: 13
- Round size: Seed $1.8M–$4.2M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Vården.se — Vården.se is Sweden's largest private search service in healthcare and health .
- Bentley — Bentley engages in the development, manufacturing for minimal-invasive treatments of vascular diseases.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Seed
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 194
- Round size: Seed $1.3M–$6.2M; Series A $3.3M–$21M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Peafowl Plasmonics — IOSBET menyediakan akses slot demo Pragmatic resmi dengan pilihan game terbanyak, pendaftaran mudah, sistem aman, serta pengalaman bermain nyaman tanpa risiko.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 106
- Round size: Seed $1.1M–$14M; Series A $4.2M–$56M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $340M in 2024
Portfolio highlights
- Biorce — Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.
- CEEZER — CEEZER is the digital infrastructure to give companies access to the complex voluntary carbon market. Deliver true climate impact now!
- Endra — Endra is a software platform for mechanical, electrical, and plumbing (MEP) engineering that automates the design, modeling, and documentation of building systems. The platform generates 2D and 3D models, calculations, schedules, diagrams, and other engineering documentation from architectural and building design inputs. It supports disciplinessuch as electrical, fire alarm, HVAC, plumbing, and sprinkler system design, and integrates with Autodesk Revit and common CAD and BIM file formats. Endra uses artificial intelligence, simulation, and computational methods to assist with tasks such as system layout, cable routing, device placement, and documentation generation while helping engineers comply with applicable design standards and regulations. The platform is designed for MEP engineers and engineering firms seeking to reduce manual design and documentation work across construction projects.
Jovitech Invest help entrepreneur-led companies to grow profitably through active, long-term ownership
Show more...Investment focus
- Industry: Solar, Medical, Recycling
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $395k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- Mat4Green Tech — Mat4Green Tech develops a technology that recycles Indium from industrial waste in an efficient and climate-neutral way.
We support early-stage founders in building global, category-defining companies. From Seed to IPO and beyond.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Sweden, Germany, United States
Investor stats
- Total investments: 276
- Round size: Seed $1.8M–$16M; Series A $5.3M–$35M; Series B $8M–$80M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- unitQ — unitQ's product quality monitoring platform empowers businesses to take a data-driven approach to product quality so they can fix the right quality issues smarter and faster.
- Pleo — Behind Pleo is the core belief to make everyone feel valued at work, driven by the mission to revolutionise business spending for forward-thinking teams everywhere - so things like a fun-to-use spend management app that automatically tracks work-related spending & generates expense reports, paired with the powerful tools businesses need tocreate full visibility and management of every penny spent.It was founded in 2015 by Jeppe Rindom and Niccolo Perra and is based in Copenhagen, Hovedstaden, Denmark.
- Trade Republic — Trade Republic is a mobile-only and commission-free broker that brings the opportunity to invest easily. The company works as a broker for a new generation for a more mobile, more intuitive, faster - and permanently free of commission. Trade Republic was founded in 2015 and based in Berlin, Germany.
Sting – Stockholm Innovation & Growth enables talented people to turn their ideas into sustainable businesses. The support they offer includes qualified coaching in business development, a business angel network, a venture capital fund, a recruitment service, and an international network of investors, business contacts and experts. Itcontribute to the success of Sweden’s future technology companies by helping them to grow and compete internationally.
Show more...Investment focus
- Industry: Software, Apps, Medical
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 16
- Round size: Seed $216k–$724k; Pre-Seed $366k–$611k
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Prion — Prion makes it quick and easy for the preschool staff to give parents insight into what happens at preschool - together with the children. The app is available free for iPhone, Android and iPad.
- Texelio — Texelio a company who is set to redefine financial market news by developing AI which empowers the customers of Retail banks, Online Brokers and Investment Service platforms.
- Minnemera — Minnemera develops digital neurocognitive tests.
LSI Academy - New education 2026, read more here
Show more...Investment focus
- Industry: Medical, Biotechnology, Biopharma
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Haga Bioscience — Haga Bioscience is a biotechnology research company.
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A
- Geography: The Netherlands, Israel, Germany
Investor stats
- Total investments: 19
- Round size: Seed $1.3M–$6.3M; Series A $3M–$20M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 17
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
- Perfat Technologies — Perfat Technologies is a health-based technology company that develops fat-management applications based on healthy vegetable oils.
LU Ventures, part of Lund University Innovation, co-founds spin-off companies with university researchers to commercialize research and drive global impact. It supports academics in building companies while allowing them to stay in academia, funding IP costs, recruiting CEOs/CTOs and board experts, and establishing legal/financialframeworks to attract external capit
Show more...Investment focus
- Industry: Medical, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 2
- Round size: Venture - Series Unknown $336k–$1.6M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
- Aventera Antibodies — Aventera Antibodies is developing a first-in-class precision immunotherapy aimed at combating invasive Group A Streptococcal disease, a severe and often life-threatening bacterial infection. By leveraging advanced antibody engineering and targeted immune modulation, the company seeks to create a highly specific treatment that can neutralize thepathogen while minimizing damage to healthy tissues.
Sweet Capital is the private investment fund of the founders of King.com (Candy Crush Saga), following their $5.9b sale to Activision Blizzard in 2015 (ATVI:US; acq. MSFT:US).
Show more...Investment focus
- Industry: Apps, Software, Mobile
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Sweden
Investor stats
- Total investments: 64
- Round size: Seed $1.8M–$5M; Series A $3M–$32M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Pachama — Harnessing AI to drive carbon capture and protect global forests
- Aula Education — Aula's created by educators to make every learning experience truly engaging. See how our simple, social platform can transform your digital learning environment.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more...Investment focus
- Industry: Medical, Biotechnology, Genetics
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 9
- Round size: Seed $772k–$2.7M; Venture - Series Unknown $2M–$5.6M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Our passionate team of company builders, financial experts, IP and legal talent ensure success for our companies.
Show more...Investment focus
- Industry: Pharmaceutical, Medical, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 8
- Round size: Seed $810k–$2.9M; Series A $2.3M–$73M; Venture - Series Unknown $794k–$1.5M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Mimbly — Mimbly creates sustainable water solution with a focus on water usage and micro-plastics. Our product The mimbox, recycles up to 70% of the water from washing machines while capturing the micro plastics released.
- NSS Water —
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Equity investment company doing Series A to late growth, private and public. Agile and long-term with no fixed holding period.
Show more...Investment focus
- Industry: Fashion, Lifestyle, Marketplace
- Stage:Seed, Series A, Series B
- Geography: Sweden, France, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $1.6M–$3.2M; Series A $3.2M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AllPlants — Discover all plants: natural, plant-based meals - ready in minutes & your easy way to 30 plants a week. Sign up now for 10% off your first order!
- BlaBlaCar — BlaBlaCar is the world’s leading long-distance carpooling community, connecting people looking to travel long distances with drivers going the same way. They travel together and share the costs of the journey. The platform is engineered to create a secure, trust-based community with declared identities and full member profiles. Members can evenspecify how chatty they are from “Bla” to “BlaBlaBla”, hence the name BlaBlaCar. BlaBlaCar is creating a global people-powered network with a trusted community of drivers and passengers.Backed by Accel Partners, Insight Ventures, Index Ventures, Lead Edge Capital, Baring Vostok and ISAI, it operates in 22 countries across Europe, Russia, Turkey, Mexico, Brazil and India. The site and free mobile apps provide a range of features to create a secure, trust-based community and easy connections between drivers and passengers.BlaBlaCar is based in Paris with offices across a dozen of countries.
- Pet Media Group — Woof Woof. Europe's Largest Pet Marketplaces PetMediaGroup is the leading operator of online marketplaces for pets and related goods and services. Through our trusted and local brands, we help thousands of animals every day to find a new loving home as well as assist their human caregivers
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series A, Series B
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 22
- Round size: Series A $2.5M–$21M; Series B $12M–$75M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
Uppsala universitet Invest AB focuses on investment management, particularly in early-stage ventures. The company collaborates with researchers and students, providing financial support and strategic guidance for innovative projects. It aims for long-term investment horizons, typically ranging from 5 to 15 years. Uppsala universitet Invest AB alsopartners with other investors and co-financiers to support research-driven initiatives.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, Health Care
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Round size: Seed $1.7M–$1.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
- Readily Diagnostics — Readily Diagnostics develops speedy and accurate diagnostic tests for respiratory disorders, enabling faster and more effective therapy at the point of care.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Series A $1.3M–$73M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Project A is an early-stage venture capital firm, combining financial and operational support for technology companies. In addition to $1bn in assets under management, Project A provides its portfolio companies with a wide range of operational support services. This includes more than 100 experts from key areas such as software engineering,business intelligence, marketing, and recruiting. The portfolio includes companies such as Trade Republic, sennder, KRY, Catawiki, WorldRemit, Spryker, and Voi.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 211
- Round size: Seed $1.5M–$10M; Series A $3.3M–$28M; Series B $11M–$75M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Linexa — Linexa develops cloud-based SaaS for decoding complex shop floor automation—parsing PLC, HMI, SCADA, and MES systems into a unified, searchable model.
- STARK — EUROPEAN DEFENCE SOVEREIGNTY
- Yoummday GmbH — yoummday‘s concept is based on the sharing economy‘s principles. Among an innovative software solution, the marketplace is matching clients and freelancing call center agents whom we call talents. Through the concept, the platform provides a solution to work as a freelancing talent globally. Moreover, the provided technology enables the possibilityfor the talents to work from home.Additionally, a customer‘s project can be implemented efficiently, individually, and flexibly. Next to a talent pool with above 20,000 registered talents, yoummday offers managed services for corporate clients, as well as a self-managing possibility. Both services are allowing the client to monitor the project in real-time based on personally defined KPI‘s. By giving talents up to 80% of the revenue, the motivation is increasing, because the freelancing talent is earning twice as much as a call center agent in their country they live in. The client only has to pay a yoummday provision as well as the talent remuneration which is leading to cost savings up to 40%. Furthermore, yoummday is responsible for training and quality checks which are regularly analyzed and individually modified.Founded in 2016 by Klaus Harisch, Pablo Harisch, and Lion Harisch, yoummday is constantly looking for motivated, self-empowering, curious, critical thinking and problem-solving employees who want to innovate the call center business. The Tech startup is constantly fast-growing and the vision is to create a brand that is an outstanding example as a leading shared economy company that is offering the main assets which are the talents an ecologically friendly way to work from home. Next to a fixed salary, employees are offered various tangible and intangible benefits that are individualized based on the needs of the employee. yoummday is a group-orientated company which is focusing on the employee as the core asset. The headquarter is based in the heart of Munich and a second branch is located in Sofia.
3T Invest started an interesting and fulfilling journey back in 2009. From the beginning they focused on the establishment of sustainable Venture Capital, supporting innovation and entrepreneurship. they are always committed to backing outstanding entrepreneurs with the necessary resources.
Show more...Investment focus
- Industry: Medical, Health Care, Lifestyle
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Linkura — Linkura offers a Lifestyle Program focusing on actions.
- Werlabs — Werlabs is a Stockholm based medical technology company founded by Will Stoddart and Rickard Lagerqvist, a general practioner. Werlabs provides customers with health analysis via blood testing. The company’s aim is to give users the tools and information to take care of their health.
- Warp News — News that is optimistic and based on facts. The world is better now than ever before, but mainstream media has a negative bias. We balance that.
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 1176
- Round size: Seed $1.4M–$16M; Series A $5M–$38M; Series B $10M–$100M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $117M in 2015
Portfolio highlights
- Monograph — A modern firm management tool for architects: a complete product for managing tasks, tracking time, and invoicing clients. Sign up for a free trial -- no credit card required.
- Supersolid — Supersolid is a leading mobile games studio based in Central London. We're here to make the most successful, genre-leading games for mobile and tablet devices. We make games that make people happy.
- Teatime Games — Teatime Games is an Iceland-based gaming startup that reinvents social games.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, Germany
Investor stats
- Total investments: 202
- Round size: Seed $1.3M–$12M; Series A $3.4M–$27M; Series B $9.4M–$58M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- Exporo — Exporo offers investors an overview of real estate projects in which they can invest easily, transparently and free of charge.The idea begins in 2013 with the realization that real estate project developers are increasingly looking for alternative sources of finance, as banks no longer finance entire projects as usual due to stricter regulation,and that private investors only have a lot of money, with good conditions and easy to invest in real estate. The result of this observation is the firm decision to develop its own online marketplace to offer real estate projects as an investment opportunity and to provide capital directly between private investors and real estate companies.Simon Brunke, Björn Maronde, Tim Bütecke and Julian Oertzen founded the online platform in 2014, they are constantly evolving and they are board members of Exporo AG. The company now employs more than 120 people and is based in Hamburg's HafenCity.
- Perk (formerly TravelPerk) — TravelPerk offers the freedom travelers want, and the control companies need. Enjoy an industry-leading travel inventory, 24/7 support and easy booking.
- Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We boldly invest in and support promising startups and potential innovations that explore new uses for sustainably-grown Nordic wood.
Show more...Investment focus
- Industry: GreenTech, Sustainability, Chemical
- Stage:Seed, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 12
- Round size: Seed $395k–$5.3M; Series A $4.4M–$8.3M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- FineCell — FineCell is a sustainable cellulose microfibers provider that enables manufacturers to make new products with reduced carbon footprints and differentiated properties.The company's cellulose microfibers possess physical and chemical properties that differ from competing products and provide differentiated benefits for the users. It has beensupported by Vinnova (Sweden’s innovation agency) and EIT InnoEnergy.The Linköping, Ostergotlands Lan-based company was established in 2015 by Jonatan Henschen, Jonas Engstrand, Monica Ek, and Kloce Dongfang Li.
- Fiberwood — Fiberwood is a new eco-friendly wood fiber insulation that can be used for a variety of purposes. Fiberwood has excellent insulating properties, is entirely bio-based, and thus contains no plastic or other fossil-based materials.
Scale Capital is an early-stage technology investor, helping Nordic, B2B, and tech founder teams scale and win in the US market.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Venture - Series Unknown
- Geography: Denmark, Norway, Sweden
Investor stats
- Total investments: 26
- Round size: Seed $1M–$4.3M; Venture - Series Unknown $1.4M–$6.1M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Sonair — Sonair is an award-winning deep tech startup building a breakthrough, patented 3D ultrasonic sensor that enables true machine autonomy by making robots safe, affordable, and efficient. Sonair was spun out from a leading European independent research organization, SINTEF, to exploit deep science-to-tech advancements in ultrasonics andMicro-ElectroMechanical Systems (MEMS). Using this technology, the company is delivering a sensor that will transform a robot’s vision from 2D to 3D, offering a significantly improved safety performance over traditional vision systems while cutting costs by 50-80%. The company, based in Oslo, Norway, was founded in 2022 by an experienced team of serial entrepreneurs led by Knut Sandven, former CEO of GasSecure.
- Bsure — Bsure AS is a Norwegian software company specializing in identity management and Microsoft 365 license optimization. Our flagship product, Bsure Insights, provides organizations with deep visibility into Entra ID users and Microsoft 365 licensing, enabling cost savings, enhanced security, and better license compliance. We help businesses gaincontrol over identities, ensuring they have the right licenses for the right users. Installed directly in the customer’s environment, Bsure Insights guarantees data privacy while delivering actionable intelligence for IT and security teams.
- All Gravy — Butter gives you happier employees, by reducing their financial stress and giving them an understanding of their salary and financial situation
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 350
- Round size: Series A $9M–$125M; Series B $12M–$135M; Series C $30M–$118M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Verana Health — Verana Health is assembling the largest clinical databases in medicine to empower physicians and accelerate research for patients.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
Investing in the crazy before it becomes normal
Show more...Investment focus
- Industry: Biotechnology, CleanTech, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 49
- Lead/follow: no public data
Portfolio highlights
- Ephos — Designing and manufacturing glass-based integrated photonic circuits that power the most advanced classical and quantum devices
- AtmoCooling — AtmoCooling transforms coastal deserts into thriving hubs of agriculture, clean energy, and climate resilience. It was founded in 2022 and operates in the USA and UAE.
- Terran Robotics — Terran Robotics is a construction company that specializes in AI and robotics. The company's headquarters are in Bloomington, Indiana.
DHS Ventures, Stockholm School of Economics alumni angel investing network that invests early on into inovative companies.
Show more...Investment focus
- Industry: Software, Big Data, Mobile Apps
- Stage:Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Divly — Divly simplifies and automates declaring taxes on your crypto trading.
- Normain — Normain is the AI platform for deep knowledge work. Automate your complex analyses and reports directly on Sharepoint or Google Drive. Access your own data and public sources in one single platform.
- Circulate — Find the best packaging for you and the planet in our marketplace
GOBIA Enterprises is owned by Jan G Smith who has been active in the pharmaceutical industry.
Show more...Investment focus
- Industry: Eyewear, Health Care, Health Diagnostics
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Annexstruktur is a venture capital firm that provides investments to companies.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
We're a traditional non-VC making data driven decisions from the heart.We fund innovation through supporting entrepreneurs that have a passion to create a market disrupting enterprises whilst making a noticeable difference in one, if not multiple of the Sustainable Development Goals set by the UN.Using AI through a dedicated data drivenprocess, we're identifying opportunities and selecting our startups and entrepreneurs based on thousands of data points from a network of partners across the globe.
Show more...Investment focus
- Industry: Medical, Biopharma
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
NeoMed Management is an international venture capital investment firm, exclusively focused on the healthcare industry. Founded in 1997, NeoMed has established five funds to date.NeoMed invests in emerging companies with outstanding growth prospects. These companies are developing innovative and proprietary medical products that addresssubstantial market opportunities in the pharmaceutical, medical device and diagnostics industries.NeoMed has a multi-stage investment approach and invests at all stages of development from start-up to later stage growth financings. Since inception, NeoMed has successfully invested in more than 30 companies in Europe, including Scandinavia, Switzerland, Germany and the UK, and in North America.From offices in Norway and Switzerland, NeoMed’s experienced investment team works closely with its entrepreneurs and a broader industry network to support the growth of its portfolio companies.NeoMed is currently focusing on NeoMed Innovation IV L.P. and NeoMed Innovation V L.P.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C
- Geography: Switzerland, United States, Italy
Investor stats
- Total investments: 40
- Lead/follow: no public data
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Oxular — Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.
- JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Bonnier Capital is the investment division of the Bonnier Group. Since 2016, we invest in promising companies in structurally growing industries and have become a reliant investment partner to companies of various sizes.
Show more...Investment focus
- Industry: Internet, Software, E-Commerce
- Stage:Seed, Series A
- Geography: Sweden, Finland, Germany
Investor stats
- Total investments: 59
- Round size: Seed $1M–$5.9M; Series A $3.4M–$21M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Acast — Want to start a podcast? Acast can help. We're the world's leading independent podcast company, helping creators and advertisers reach listeners globally.
- AAC Clyde Space —
- Mediaflow Europe — Mediaflow Europe is a SaaS company that provides its platform for image, video, design, templates, and document sharing and management.
Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.
Show more...Investment focus
- Industry: Software, Analytics, Semiconductor
- Stage:Series A, Series B, Seed
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 45
- Round size: Seed $1.1M–$3.3M; Series A $3.9M–$8.8M; Series B $2.4M–$16M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $60M in 2010
Portfolio highlights
- Blackwood Seven — Blackwood Seven is a media analytics platform which strives to increase the effect of company’s media spend using our predictive analytics framework built on machine learning and artificial intelligence. Using real-time modelling and advanced KPI prediction we are able to increase a company’s media ROI by up to 15-25%.
- Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
- Aito Technologies — We are a world leader in Customer Experience Analytics for mobile operators. Aito provides better understanding and management the entire customer life cycle helping them identify key relationships and the context between business drivers, customer segments, networks, services, and devices, throughout the customer life cycle.
We help great minds unleash their full potential!
Show more...Investment focus
- Industry: SaaS, Energy, Software
- Stage:Seed, Pre-Seed
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 35
- Round size: Seed $772k–$3.7M; Pre-Seed $826k–$8.2M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — raised $53M in 2022
Portfolio highlights
- Tavion — Tavion is a developer of battery energy storage systems that is expediting Europe's shift to renewable energy. Tavion creates and runs utility-scale BESS infrastructure to improve grid flexibility, stabilize intermittent renewable power, and promote energy independence in European markets.
- CemVision — CemVision is an industrial tech company that has been developing CO2-free cement.
- Helios Innovations — Helios Innovations is an industrial machinery manufacturing industry that develops modular and electrical evaporation plants for water.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Denmark, Sweden, Switzerland
Investor stats
- Total investments: 60
- Round size: Series A $5.5M–$43M; Series B $9.6M–$52M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $94M in 2019
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Resalis Therapeutics — Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 87
- Round size: Seed $373k–$2.1M; Pre-Seed $110k–$4.3M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
- CooliBlade — Superior power electronics cooling solutions for applications like solar and wind energy, energy storage, EV charging and telecommunications.
- Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Incos Invest is a venture capital firm specializing in start-up and early-stage investments. The firm seeks to make investments in companies operating in the industries of cosmetics, perfumes, travel and tourism, real estate, e-commerce, IT, and software development. The company is headquartered in Skane Lan, Sweden.
Show more...Investment focus
- Industry: Travel, Boating, Medical
- Stage:Seed, Convertible Note
- Geography: Italy, Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antlos — Antlos is a peer-to-peer online marketplace that offers all-inclusive experience-driven boat holidays, published and managed directly by local Skippers, who are the captains and owners of the boat. Based on the principles of a Sharing Economy, Antlos makes yachting simple, affordable and accessible to everyone.Every Skipper may publish severallistings and be contacted by registered users willing to book a holiday. Guests can choose from different destinations and experiences offered and safely pay online via credit card, Paypal and Bank Wire. The Skippers can start earning from the rental of their boat without having to pay any agency fees and clients can book their holidays easily and safely thanks to Antlos' flexible cancellation policies and clear terms and conditions.Antlos was born in Venice and grown in H-FARM Campus. The team is composed of young professionals, passionate and expert on travel and the maritime industry, coming from different work experiences. Recently Antlos has been merged with the Swiss company which runs Sailogy.com.
- Joint Academy — Joint Academy connects patients with licensed physical therapists to deliver online treatments for chronic joint and back pain. Our treatments are clinically proven and give patients access to a personal, licensed physical therapist, an individualized exercise plan, interactive education about the condition, and progress tracking — all through auser-friendly app. Peer-reviewed studies show that Joint Academy patients reduce their pain, change their minds about surgery, and quit painkillers. Joint Academy is now available to patients in Sweden, the US, the UK, France, and Germany.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 200
- Round size: Series A $19M–$176M; Series B $16M–$155M; Series C $19M–$113M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
- Inflazome — Situs gacor premium Megawin188 paling banyak di minati oleh semua kalangan karena pecah selayar tanpa henti dan memiliki tampilan yang sangat memanjakan mata.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
20 North Street is the name HDR Partners uses when adding investors and industrial experience to small growth companies.
Show more...Investment focus
- Industry: Medical, mHealth, Wireless
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Coala Life — Coala Life is a Swedish medical technology and life science company that focuses on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and theCoala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments.
Ferd er et familieeid investeringsselskap som er eid av femte og sjette generasjon Andresen.
Show more...Investment focus
- Industry: Software, Energy, Information Technology
- Stage:Private Equity, Series A
- Geography: Norway, Sweden, United States
Investor stats
- Total investments: 59
- Round size: Series A $2.2M–$13M; Private Equity $11M–$14M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2005
Portfolio highlights
- wheel.me — The first and only autonomous wheel in the world. The innovation transforms anything into an autonomous mobile robot with minimal effort and without the need to alter its design or form. The company was founded in 2013 and is headquartered in Oslo, Norway.
- Nofence — Manage your livestock from anywhere with GPS collars and a simple app. Unlock more acres, cut fencing costs, and run your operation on your terms.
- Kvist Solutions — Kvist Solutions tilbyr programvare som forenkler BREEAM sertifisering. Vi gir deg oversikt over hele prosjektet, slik at veien til sertifisering blir oversiktlig og forutsigbar.
First partner to exceptional teams everywhere
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1947
- Round size: Seed $1.6M–$11M; Series A $4.5M–$41M; Series B $9.5M–$74M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $14M in 2019
Portfolio highlights
- Campfire — Campfire is the AI-native ERP built for high-growth finance teams. Automate reconciliations, close faster, and scale revenue without adding headcount.
- Altor Networks — HARPATOTO merupakan sebuah portal akses online yang dirancang untuk memudahkan pengguna terhubung ke layanan Toto Macau dengan cepat, stabil, dan aman.
- Shift Technology — Shift Technology delivers AI-native decision automation and optimization solutions built specifically for the global insurance industry. Addressing several critical processes across the insurance policy lifecycle, Shift helps insurers achieve faster, more accurate claims and policy resolutions. Shift has analyzed billions of insurance transactionsto date and was presented Frost & Sullivan’s 2020 Global Claims Solutions for Insurance Market Leadership Award.
Medical VC funding in Sweden at a glance
Stats across 228 deals from 209 investors.
Access all 209 VC funds in Sweden Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 209 VC funds investing in Sweden Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!